Shopping Cart
Remove All
Your shopping cart is currently empty
Manelimab is a humanized monoclonal antibody targeting Programmed death-ligand 1(PD-L1). By blocking the interaction between PD-L1 and its receptor PD-1, it can relieve the immunosuppression of T cells, thus enhancing the anti-tumor immune response. Manelimab is mainly used to explore the mechanism of tumor immunotherapy.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry |
| Description | Manelimab is a humanized monoclonal antibody targeting Programmed death-ligand 1(PD-L1). By blocking the interaction between PD-L1 and its receptor PD-1, it can relieve the immunosuppression of T cells, thus enhancing the anti-tumor immune response. Manelimab is mainly used to explore the mechanism of tumor immunotherapy. |
| In vitro | Manelimab binds human IL-10Ra with high affinity, triggering STAT3 phosphorylation and mimicking IL-10 signaling. It dose-dependently inhibits the secretion of pro-inflammatory cytokines (e.g., TNF-alpha, IL-6) in LPS-stimulated monocytes at nanomolar (nM) concentrations [1]. |
| Synonyms | BCD-135 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | PD-L1 |
| Cas No. | 2168561-26-8 |
| Isotype | IgG1 |
| Storage | Store at -20°C Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.